A First-in-Human, Phase 1, Dose Escalation Study of Sgr-2921 As Monotherapy in Subjects with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeCourtney D. DiNardo, Stephen Anthony Strickland, Barry Skikne,Amer M. Zeidan,Elie Traer,Hetty E. Carraway,Stanley Frankel, Daniel E Weiss, Jacky H Wang,Steven Pirie-Shepherd, Joseph Piccotti,D. Hamish Wright,Karen AkinsanyaBlood(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要